McKesson Corp. Coverage Initiated at Goldman Sachs (MCK)
Equities research analysts at Goldman Sachs initiated coverage on shares of McKesson Corp. (NYSE:MCK) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock.
A number of other analysts have also recently weighed in on MCK. Analysts at Zacks reiterated a “neutral” rating on shares of McKesson Corp. in a research note on Friday, February 7th. They now have a $181.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. initiated coverage on shares of McKesson Corp. in a research note on Friday, February 7th. They set an “overweight” rating on the stock. Finally, analysts at Sterne Agee raised their price target on shares of McKesson Corp. from $185.00 to $203.00 in a research note on Friday, January 31st. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $182.53.
McKesson Corp. (NYSE:MCK) traded up 0.26% on Wednesday, hitting $177.94. The stock had a trading volume of 815,799 shares. McKesson Corp. has a 52-week low of $101.78 and a 52-week high of $179.00. The stock has a 50-day moving average of $170.5 and a 200-day moving average of $149.2. The company has a market cap of $40.949 billion and a P/E ratio of 36.04.
McKesson Corp. (NYSE:MCK) last issued its quarterly earnings data on Friday, January 31st. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.85 by $0.40. The company had revenue of $34.30 billion for the quarter, compared to the consensus estimate of $38.57 billion. On average, analysts predict that McKesson Corp. will post $8.18 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 0.54%. The ex-dividend date is Thursday, February 27th.
McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.